Synergy with HRT : They combine effectively with hormone therapy for compounded benefits.[4-6] However, alternatives exist for those seeking different approaches
The FDA-approved dose for weight management is 2.4 mg weekly (Wegovy), which is higher than the 0.5-1.0 mg doses used for diabetes management
Semaglutide Dosing Schedule With standard FDA-approved dosing, semaglutide starts at 0.25 mg once weekly for the first 4 weeks, then increases gradually every 4 weeks through a structured progression: 0.25 mg 0.5 mg 1.0 mg 1.7 mg 2.4 mg
This hormone performs several key functions: Insulin Secretion: It tells the pancreas to release insulin when blood sugar levels are high
Potential Side Effects and Digestive Changes The most common adverse effects of Wegovy involve the gastrointestinal system, with nausea, diarrhoea, vomiting, constipation, and abdominal pain reported in clinical trials, as detailed in the MHRA-approved SmPC
This PEPTAS listing identifies a nominal 6mg research quantity